2018 Annual Conference on Vaccinology Research

OA3-3 Phase 1 Study of a Pentavalent Meningococcal Conjugate Vaccine (ACYWX)

Tuesday, April 24
2:00 PM - 2:15 PM

A pentavalent meningococcal conjugate vaccine targeting A, C, Y, W, and X serogroups (NmCV-5) was evaluated in a first-in-human phase 1 study.

Wilbur H. Chen, MD

Associate Professor
University of Maryland School of Medicine

Dr. Wilbur Chen is an Associate Professor of Medicine at the University of Maryland School of Medicine, where he is the Chief of the Adult Clinical Studies section at the Center for Vaccine Development and Director of the University of Maryland, Baltimore Travel Medicine Practice. He is a board-certified infectious disease physician with a focus on vaccinology and his primary research interests are two-fold: developing vaccines for the elderly (a rapidly growing segment of the global population which is susceptible to infection) and developing vaccines for enteric pathogens (diseases chiefly of resource poor and economically disadvantaged countries). Dr. Chen is an active investigator within the NIAID-supported Vaccine and Treatment Evaluation Unit (VTEU), Co-PI of the clinical core of an NIAID-funded Cooperative Center for Human Immunology (CCHI), was the PI of the NIAID-supported Food and Waterborne Diseases Integrated Research Network Clinical Research Unit (FWD IRN CRU).

Presentation(s):

Send Email for Wilbur Chen


Assets

OA3-3 Phase 1 Study of a Pentavalent Meningococcal Conjugate Vaccine (ACYWX)

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for OA3-3 Phase 1 Study of a Pentavalent Meningococcal Conjugate Vaccine (ACYWX)